Abstract

Nowadays, similar strategies have been used for the treatment and prevention of acute stroke in both diabetes mellitus (DM) and non-DM populations. These strategies were analyzed to provide an experimental basis for the clinical prevention and treatment of stroke in patients both with and without DM. Tree shrews were randomly divided into control, DM, ischemic stroke (IS), and DMIS groups with 18 animals in each group. Serum biochemical indicators were used to assess metabolic status. Neural tissue damage was determined using triphenyl tetrazolium chloride staining, H-E staining, and electron microscopy. Differential gene expression of neural tissue between the DM and control groups and the IS and DMIS groups was measured using RNA-seq analysis. The serum glucose levels of the DM and DMIS groups were significantly higher than other groups. In the DMIS group, the infarct size was significantly larger than in the IS group (19.56 ± 1.25%), with a more obvious abnormal ultrastructure of neural cells. RNA-seq analysis showed that the expression of IL-8, C-C motif chemokine 2 (CCL2), and alpha-1-antichymotrypsin was significantly higher in the DM group than in the control group. The CCL7, ATP-binding cassette sub-family A member 12, and adhesion G protein-coupled receptor E2 levels were significantly higher in the DMIS group than in the IS group. For the prevention and treatment of stroke in patients with DM, reducing the inflammatory state of the nervous system may reduce the incidence of stroke and improve the prognosis of neurological function after IS.

Highlights

  • Stroke is the leading cause of adult disability and mortality worldwide (Collaborators GBDS, 2019)

  • For the prevention and treatment of stroke in patients with diabetes mellitus (DM), reducing the inflammatory state of the nervous system may reduce the incidence of stroke and improve the prognosis of neurological function after ischemic stroke (IS)

  • The tree shrews were randomly divided into four groups, namely, the control, DM, ischemia stroke (IS), and DMIS, with 18 animals per group (Figure 1)

Read more

Summary

Introduction

Stroke is the leading cause of adult disability and mortality worldwide (Collaborators GBDS, 2019). Diabetes mellitus (DM) is an important risk factor for stroke, and patients with DM are 2-6 times more likely to experience a stroke (Jiang et al, 2018; Ma et al, 2018). Similar strategies have been used for the treatment and prevention of acute stroke in both diabetes mellitus (DM) and non-DM populations.

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.